PMID- 27951472 OWN - NLM STAT- MEDLINE DCOM- 20171229 LR - 20180709 IS - 1873-4847 (Electronic) IS - 0955-2863 (Linking) VI - 40 DP - 2017 Feb TI - Soy protein concentrate mitigates markers of colonic inflammation and loss of gut barrier function in vitro and in vivo. PG - 201-208 LID - S0955-2863(16)30753-7 [pii] LID - 10.1016/j.jnutbio.2016.11.012 [doi] AB - Whereas a number of studies have examined the effects of soy isoflavones and tocopherols on colonic inflammation, few have examined soy protein. We determined the radical scavenging and cytoprotective effects of soy protein concentrate (SPC) in vitro and its anti-inflammatory effects in dextran sulfate sodium (DSS)-treated mice. Cotreatment with SPC protected Caco-2 human colon cells from H(2)O(2)-induced cell death and mitigated intracellular oxidative stress. Treatment of differentiated Caco-2 cells with SPC blunted DSS-induced increases in monolayer permeability. Pepsin/pancreatin-digested SPC had reduced radical scavenging activity, but retained the monolayer protective effects of SPC. In vivo, 1.5% DSS caused body weight loss, colon shortening, and splenomegaly in CF-1 mice. Co-treatment with 12% SPC mitigated DSS-induced body weight loss and splenomegaly. DSS increased colonic interleukin (IL)-1beta, IL-6, and monocyte chemotactic protein-1 expression. The levels of these markers were significantly lower in mice co-treated with SPC. SPC prevented DSS-mediated reductions in colonic glucagon-like peptide 2 levels, suggesting that SPC can prevent loss of gut barrier function, but no significant effect on claudin 1 and occludin mRNA levels of was observed. SPC-treated mice had lower colonic mRNA expression of toll-like receptor 4 and nucleotide-binding oligomerization domain-containing protein-like receptor family, pyrin domain containing protein 3 (NLRP3), and lower caspase-1 enzyme activity than DSS-treated mice. In summary, SPC exerted antioxidant and cytoprotective effects in vitro and moderated the severity of DSS-induced inflammation and loss of gut barrier function in vivo. These effects appear to be mediated in part through reduced NLRP3 expression and caspase 1 activity. CI - Copyright (c) 2016. Published by Elsevier Inc. FAU - Bitzer, Zachary T AU - Bitzer ZT AD - Department of Food Science, The Pennsylvania State University, University Park, PA, 16802, USA. FAU - Wopperer, Amy L AU - Wopperer AL AD - Department of Food Science, The Pennsylvania State University, University Park, PA, 16802, USA. FAU - Chrisfield, Benjamin J AU - Chrisfield BJ AD - Department of Food Science, The Pennsylvania State University, University Park, PA, 16802, USA. FAU - Tao, Ling AU - Tao L AD - Department of Food Science, The Pennsylvania State University, University Park, PA, 16802, USA. FAU - Cooper, Timothy K AU - Cooper TK AD - Department of Comparative Medicine and Department of Pathology, College of Medicine, The Pennsylvania State University, Hershey, PA, 17033, USA. FAU - Vanamala, Jairam AU - Vanamala J AD - Department of Food Science, The Pennsylvania State University, University Park, PA, 16802, USA. FAU - Elias, Ryan J AU - Elias RJ AD - Department of Food Science, The Pennsylvania State University, University Park, PA, 16802, USA. FAU - Hayes, John E AU - Hayes JE AD - Department of Food Science, The Pennsylvania State University, University Park, PA, 16802, USA. FAU - Lambert, Joshua D AU - Lambert JD AD - Department of Food Science, The Pennsylvania State University, University Park, PA, 16802, USA; Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA 16802, USA. Electronic address: jdl134@psu.edu. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20161127 PL - United States TA - J Nutr Biochem JT - The Journal of nutritional biochemistry JID - 9010081 RN - 0 (Antioxidants) RN - 0 (Biomarkers) RN - 0 (Ccl2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Glucagon-Like Peptide 2) RN - 0 (Inflammasomes) RN - 0 (Interleukin-1beta) RN - 0 (Interleukin-6) RN - 0 (Soybean Proteins) RN - 9042-14-2 (Dextran Sulfate) SB - IM MH - Animals MH - Antioxidants/pharmacology MH - Biomarkers/metabolism MH - Caco-2 Cells MH - Chemokine CCL2/metabolism MH - Colitis/chemically induced/*drug therapy/*physiopathology MH - Dextran Sulfate/toxicity MH - Glucagon-Like Peptide 2/metabolism MH - Humans MH - Inflammasomes/drug effects MH - Interleukin-1beta/metabolism MH - Interleukin-6/metabolism MH - Male MH - Mice, Inbred Strains MH - Permeability MH - Soybean Proteins/chemistry/*pharmacology OTO - NOTNLM OT - Colitis OT - Dextran sulfate sodium OT - Gastrointestinal permeability OT - Glycine max OT - Inflammasome OT - Soy protein EDAT- 2016/12/13 06:00 MHDA- 2017/12/30 06:00 CRDT- 2016/12/13 06:00 PHST- 2015/04/13 00:00 [received] PHST- 2016/11/18 00:00 [revised] PHST- 2016/11/23 00:00 [accepted] PHST- 2016/12/13 06:00 [pubmed] PHST- 2017/12/30 06:00 [medline] PHST- 2016/12/13 06:00 [entrez] AID - S0955-2863(16)30753-7 [pii] AID - 10.1016/j.jnutbio.2016.11.012 [doi] PST - ppublish SO - J Nutr Biochem. 2017 Feb;40:201-208. doi: 10.1016/j.jnutbio.2016.11.012. Epub 2016 Nov 27.